The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
9, 2023 — High fiber diets, like those that include broccoli sprouts or other cruciferous vegetables, may reduce disease symptoms and improve quality of life in patients with inflammatory bowel ...
Symptoms & Types There are many types of heart disease. Here's where to get quick facts on each one -- including warning signs and symptoms. Symptoms Heart Disease Warning Signs Types of Heart ...